Splash Beverage Expands Exclusive Global License For CannEpil To Include Veterinary Therapeutic Applications

Splash Beverage Group, Inc. (NYSE:SBEV) ("Splash" or the "Company") today announced that it has expanded its exclusive global license for CannEpil® to include veterinary therapeutic applications, creating a second regulated pharmaceutical development platform alongside the Company's existing human pharmaceutical program.

The expanded field of use grants Splash exclusive worldwide rights to develop, manufacture, commercialize, market and distribute CannEpil for veterinary diseases and conditions.